Stay updated on Hydroxychloroquine, Zinc, Azithromycin, Doxy Clinical Trial
Sign up to get notified when there's something new on the Hydroxychloroquine, Zinc, Azithromycin, Doxy Clinical Trial page.

Latest updates to the Hydroxychloroquine, Zinc, Azithromycin, Doxy Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a site maintenance/update and does not change study content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a Locations section listing Roslyn, New York, United States as a study site. Updated the page to revision v3.3.3 and removed the prior New York Locations entry and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded Revision: v3.3.2 and deleted Revision: v3.2.0 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedA funding/operating status notice was removed from the page. This change does not affect study details, eligibility criteria, outcomes, or enrollment information.SummaryDifference0.4%

- Check74 days agoChange DetectedThe updates appear to be minor UI and textual adjustments with no changes to core study details (eligibility criteria, interventions, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check103 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

Stay in the know with updates to Hydroxychloroquine, Zinc, Azithromycin, Doxy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Hydroxychloroquine, Zinc, Azithromycin, Doxy Clinical Trial page.